Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome

NCT05298475 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Statin
DRUG: PCSK9 inhibitor
DRUG: PCSK9 inhibitor

Sponsor

The First Affiliated Hospital with Nanjing Medical University